Einar Gudlaugsson

2.6k citations

89 papers · 1.8k indexed · h-index 25

Co-authors: Ivar Skaland Jan P. A. Baak Emiel A. M. Janssen Håvard Søiland Jon Arne Søreide Anaís Malpica Kjetil Søreide Jan Kłos
Topics: Breast Cancer Treatment Studies (24 papers)Cervical Cancer and HPV Research (16 papers)Endometrial and Cervical Cancer Treatments (14 papers)
Cited by: Cancer Research Oncology Obstetrics and Gynecology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Norway Netherlands United States

In The Last Decade

Einar Gudlaugsson

87 papers receiving 1.8k citations

Peers

Countries citing papers authored by Einar Gudlaugsson

Since Specialization

Citations

This map shows the geographic impact of Einar Gudlaugsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einar Gudlaugsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einar Gudlaugsson more than expected).

Fields of papers citing papers by Einar Gudlaugsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einar Gudlaugsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einar Gudlaugsson. The network helps show where Einar Gudlaugsson may publish in the future.

Co-authorship network of co-authors of Einar Gudlaugsson

This figure shows the co-authorship network connecting the top 25 collaborators of Einar Gudlaugsson. A scholar is included among the top collaborators of Einar Gudlaugsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einar Gudlaugsson. Einar Gudlaugsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence-assisted prostate cancer diagnosis for reduced use of immunohistochemistry 2025 ·Communications Medicine ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Marcello Gambacorta,(unknown),Einar Gudlaugsson,Svein Reidar Kjosavik,Lars Egevad,Emiel A. M. Janssen,Martin Eklund,Kimmo Kartasalo	0
2	Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence 2023 ·Modern Pathology ·(unknown),Einar Gudlaugsson,(unknown),Ivar Skaland,Jan P. A. Baak,Emiel A. M. Janssen	4
3	A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment 2021 ·Cancer Immunology Immunotherapy ·(unknown),Martin Watson,Ivar Skaland,Hanne R. Hagland,(unknown),Einar Gudlaugsson,Kjetil Søreide	11
4	<p>Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients</p> 2020 ·Clinical Epidemiology ·(unknown),Kristín Jónsdóttir,(unknown),Ivar Skaland,Cathrine F. Hjorth,Einar Gudlaugsson,Stephen Hamilton‐Dutoit,Timothy L. Lash,Deirdre Cronin‐Fenton,Emiel A. M. Janssen	4
5	Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer 2020 ·PLoS ONE ·(unknown),(unknown),(unknown),Einar Gudlaugsson,(unknown),Ivar Skaland,Jan P. A. Baak,Emiel A. M. Janssen	5
6	Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients 2019 ·PLoS ONE ·(unknown),Marie Austdal,(unknown),(unknown),Einar Gudlaugsson,Jan P. A. Baak,Ivar Skaland,Emiel A. M. Janssen,Kristín Jónsdóttir	8
7	Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial 2019 ·BMC Cancer ·Tone Hoel Lende,Marie Austdal,(unknown),Ivar Skaland,Einar Gudlaugsson,Jan Terje Kvaløy,Lars A. Akslen,Håvard Søiland,Emiel A. M. Janssen,Jan P. A. Baak	15
8	The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer 2013 ·PLoS ONE ·Marie Klintman,Carina Strand,Cecilia Ahlin,(unknown),Marie-Louise Fjällskog,Dorthe Grabau,Einar Gudlaugsson,Emiel A. M. Janssen,Kristina Lövgren,Ivar Skaland,Pär‐Ola Bendahl,Per Malmström,Jan P. A. Baak,Mårten Fernö	24
9	Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade? 2013 ·PLoS ONE ·Weiwei Feng,Anaís Malpica,Ivar Skaland,Einar Gudlaugsson,Stanley J. Robboy,Ingvild Dalen,Keqin Hua,Xianrong Zhou,Jan P. A. Baak	12
10	Prognostic Value of the Diagnostic Criteria Distinguishing Endometrial Stromal Sarcoma, Low Grade From Undifferentiated Endometrial Sarcoma, 2 Entities Within the Invasive Endometrial Stromal Neoplasia Family 2012 ·International Journal of Gynecological Pathology ·Weiwei Feng,Anaís Malpica,Stanley J. Robboy,Einar Gudlaugsson,Keqin Hua,Xianrong Zhou,Jan P. A. Baak	15
11	The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer 2012 ·Breast Cancer Research and Treatment ·Kristín Jónsdóttir,Hui Zhang,(unknown),Ivar Skaland,(unknown),Benny Björkblom,Eleanor T. Coffey,Einar Gudlaugsson,Rune Smaaland,Emiel A. M. Janssen,Jan P. A. Baak	19
12	High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases 2011 ·Cellular Oncology ·(unknown),Anaís Malpica,(unknown),Einar Gudlaugsson,Emiel A. M. Janssen,Mark J. Arends,Arnold‐Jan Kruse,Yinhua Yu,Weiwei Feng,Jan P. Baak	12
13	Epidemiology of gastrointestinal stromal tumours: Single-institution experience and clinical presentation over three decades 2011 ·Cancer Epidemiology ·Oddvar M. Sandvik,Kjetil Søreide,Jan Terje Kvaløy,Einar Gudlaugsson,Jon Arne Søreide	47
14	Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression 2010 ·Modern Pathology ·Irene Tveiterås Øvestad,Einar Gudlaugsson,Ivar Skaland,Anaís Malpica,Arnold‐Jan Kruse,Emiel A. M. Janssen,Jan P. A. Baak	59
15	Biologic profiling of lymph node negative breast cancers by means of microRNA expression 2010 ·Modern Pathology ·Emiel A. M. Janssen,(unknown),Einar Gudlaugsson,Kristín Jónsdóttir,Ivar Skaland,Håvard Søiland,Jan P. A. Baak	56
16	The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer. 2009 ·SHILAP Revista de lepidopterología ·Ivar Skaland,Emiel A. M. Janssen,Einar Gudlaugsson,(unknown),Jan P. A. Baak	26
17	Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ 2008 ·Human Pathology ·Arnold‐Jan Kruse,Ivar Skaland,(unknown),Emiel A. M. Janssen,Einar Gudlaugsson,Jan P. A. Baak	4
18	Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers 2007 ·Annals of Oncology ·Jan P. A. Baak,P. J. van Diest,Emiel A. M. Janssen,Einar Gudlaugsson,Feja J. Voorhorst,Elsken van der Wall,Jan B. Vermorken	23
19	Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age 2007 ·Modern Pathology ·Ivar Skaland,Emiel A. M. Janssen,Einar Gudlaugsson,Jan Kłos,Kjell H. Kjellevold,Håvard Søiland,Jan P. A. Baak	91
20	Analysis of clonality in archival tissues by polymerase chain reaction amplification of PGK-1 1994 ·Human Pathology ·Kenneth R. Shroyer,Einar Gudlaugsson	23

About Einar Gudlaugsson

Einar Gudlaugsson is a scholar working on Cancer Research, Obstetrics and Gynecology and Oncology, having authored 89 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), Cervical Cancer and HPV Research (16 papers) and Endometrial and Cervical Cancer Treatments (14 papers). The work is most often cited by research in Cancer Research (599 citations), Oncology (699 citations) and Obstetrics and Gynecology (161 citations). Einar Gudlaugsson has collaborated with scholars based in Norway, Netherlands and United States. Frequent co-authors include Ivar Skaland, Jan P. A. Baak, Emiel A. M. Janssen, Emiel A. M. Janssen, Håvard Søiland, Jon Arne Søreide, Anaís Malpica, Kjetil Søreide, Jan Kłos and Jan P. A. Baak. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact